UCLA Luskin research investigates healthcare market consolidation effects and public option insurance's role in reducing costs and improving affordability in the U.S. health sector.

Less than 15% of U.S. cancer survivors with alcohol use disorder start treatment within one year, indicating gaps in AUD care and treatment initiation.

Explore how the Advisory Board supports healthcare leaders with insights and strategies on industry trends, FDA approvals, AI, and health equity shaping the U.S. insurance and healthcare sectors.